Talmi Y P, Finkelstein Y, Zohar Y, Laurian N
Department of Otolaryngology, Golda Medical Center, Hasharon Hospital, Petah-Tiqva, Israel.
Ann Otol Rhinol Laryngol. 1988 Mar-Apr;97(2 Pt 1):128-30. doi: 10.1177/000348948809700206.
Scopoderm transdermal therapeutic system (TTS) is a form of application permitting programmed release of scopolamine through the skin into the bloodstream. Scopoderm TTS is indicated for prevention of nausea and vomiting associated with motion sickness. The most common side effect associated with its use is dryness of the mouth. We have been using Scopoderm TTS for reducing salivary flow in patients with sialorrhea or with difficulties in swallowing normal amounts of salivary secretions. Good results were achieved with minimal discomfort from adverse effects. We recommend the use of Scopoderm TTS in selected cases of sialorrhea and drooling, preoperatively and postoperatively in patients undergoing surgery of oral, laryngeal, and pharyngeal lesions.
东莨菪碱透皮治疗系统（TTS）是一种给药形式，可使东莨菪碱通过皮肤编程释放进入血液循环。东莨菪碱透皮治疗系统适用于预防晕动病相关的恶心和呕吐。使用该药物最常见的副作用是口干。我们一直在使用东莨菪碱透皮治疗系统来减少流涎或吞咽正常量唾液分泌物有困难患者的唾液分泌。在不良反应引起的不适最小的情况下取得了良好效果。我们建议在某些流涎和流口水的病例中，以及在口腔、喉部和咽部病变手术患者的术前和术后使用东莨菪碱透皮治疗系统。
